Schrodinger (NASDAQ:SDGR) EVP Yvonne Tran Sells 1,094 Shares of Stock

Schrodinger, Inc. (NASDAQ:SDGRGet Free Report) EVP Yvonne Tran sold 1,094 shares of the company’s stock in a transaction on Thursday, March 5th. The shares were sold at an average price of $12.89, for a total value of $14,101.66. Following the transaction, the executive vice president directly owned 52,683 shares in the company, valued at approximately $679,083.87. The trade was a 2.03% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Yvonne Tran also recently made the following trade(s):

  • On Tuesday, February 10th, Yvonne Tran sold 776 shares of Schrodinger stock. The shares were sold at an average price of $13.80, for a total value of $10,708.80.

Schrodinger Price Performance

NASDAQ SDGR traded down $0.29 during trading hours on Friday, hitting $12.74. The company’s stock had a trading volume of 976,433 shares, compared to its average volume of 1,680,207. Schrodinger, Inc. has a 12 month low of $11.11 and a 12 month high of $27.63. The company’s 50 day simple moving average is $14.77 and its two-hundred day simple moving average is $17.59. The company has a market cap of $938.56 million, a P/E ratio of -8.97 and a beta of 1.57.

Schrodinger (NASDAQ:SDGRGet Free Report) last posted its earnings results on Wednesday, February 25th. The company reported $0.44 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.13) by $0.57. The business had revenue of $87.24 million for the quarter, compared to analysts’ expectations of $83.66 million. Schrodinger had a negative net margin of 40.37% and a negative return on equity of 29.47%. The business’s revenue for the quarter was up 4.7% compared to the same quarter last year. During the same quarter in the prior year, the business earned ($0.24) EPS. As a group, research analysts predict that Schrodinger, Inc. will post -2.37 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Schrodinger

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Massachusetts Financial Services Co. MA increased its stake in shares of Schrodinger by 38.7% in the third quarter. Massachusetts Financial Services Co. MA now owns 2,072,433 shares of the company’s stock worth $41,573,000 after purchasing an additional 577,899 shares in the last quarter. Capital Fund Management S.A. purchased a new position in shares of Schrodinger during the 2nd quarter valued at $1,486,000. Sumitomo Mitsui Trust Group Inc. boosted its holdings in Schrodinger by 24.8% in the 3rd quarter. Sumitomo Mitsui Trust Group Inc. now owns 4,554,569 shares of the company’s stock worth $91,365,000 after buying an additional 904,619 shares during the period. Citigroup Inc. boosted its holdings in Schrodinger by 122.5% in the 3rd quarter. Citigroup Inc. now owns 155,209 shares of the company’s stock worth $3,113,000 after buying an additional 85,448 shares during the period. Finally, Nikko Asset Management Americas Inc. increased its stake in Schrodinger by 7.2% in the 2nd quarter. Nikko Asset Management Americas Inc. now owns 2,591,492 shares of the company’s stock worth $52,089,000 after buying an additional 174,684 shares in the last quarter. 79.05% of the stock is owned by hedge funds and other institutional investors.

Schrodinger News Summary

Here are the key news stories impacting Schrodinger this week:

  • Positive Sentiment: Yahoo Finance piece highlights an evolving investment thesis as Schrödinger shifts toward hosted software and resets targets, which could support longer-term sentiment if adoption and ARR trajectory improve. How The Schrödinger (SDGR) Investment Story Is Evolving With Hosted Software And Reset Targets
  • Neutral Sentiment: Transcript from Schrödinger’s TD Cowen conference presentation provides management commentary and detail that investors can use to re-assess guidance, product roadmap and commercialization progress; useful but not an immediate catalyst. Schrödinger, Inc. (SDGR) Presents at TD Cowen 46th Annual Health Care Conference Transcript
  • Negative Sentiment: CEO Ramy Farid sold 3,661 shares at an average $12.91 (≈1.09% reduction in his stake), a high-profile insider sale that can signal near-term selling pressure. CEO Form 4
  • Negative Sentiment: CFO Rachit Jain sold 1,631 shares at ~$12.90 (≈3.01% reduction), adding to the cluster of exec sales that market participants often interpret as a negative signal. CFO Form 4
  • Negative Sentiment: Other senior leaders (EVPs Kenneth Lorton and Yvonne Tran, CAO Jenny Herman, and insiders Robert Abel, Karen Akinsanya) executed small-to-moderate sales (roughly 600–1,366 shares each around $12.80–$12.91), collectively reducing insider holdings and contributing to downward pressure. Sample Insider Filing (Robert Abel)
  • Negative Sentiment: Multiple filings show these sales occurred within a short window (Mar 4–6), which magnifies market reaction compared with isolated, scheduled sales; however, each sale is a small percentage of total insider stakes and could reflect diversification or option/vesting activity rather than a change in corporate outlook. SEC Filings

Analyst Ratings Changes

A number of research firms have recently issued reports on SDGR. Weiss Ratings restated a “sell (e+)” rating on shares of Schrodinger in a research note on Friday, January 9th. Wall Street Zen raised shares of Schrodinger from a “sell” rating to a “hold” rating in a report on Saturday, January 31st. TD Cowen reiterated a “buy” rating on shares of Schrodinger in a research note on Thursday, January 8th. Bank of America raised shares of Schrodinger from a “neutral” rating to a “buy” rating and set a $24.00 price objective for the company in a research report on Monday, December 15th. Finally, KeyCorp reduced their price objective on Schrodinger from $28.00 to $25.00 and set an “overweight” rating for the company in a research note on Thursday, January 8th. Four analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, Schrodinger presently has an average rating of “Hold” and an average price target of $21.75.

View Our Latest Research Report on Schrodinger

About Schrodinger

(Get Free Report)

Schrödinger, Inc is a life sciences and materials discovery company that specializes in the application of physics-based computational platforms to accelerate drug discovery and advanced materials design. Founded in 1990 by Professor Richard A. Friesner, Schrödinger has developed a suite of proprietary software tools—such as Maestro for molecular modeling, Glide for molecular docking and Jaguar for quantum chemistry calculations—that enable scientists to predict molecular behavior with high accuracy.

See Also

Insider Buying and Selling by Quarter for Schrodinger (NASDAQ:SDGR)

Receive News & Ratings for Schrodinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Schrodinger and related companies with MarketBeat.com's FREE daily email newsletter.